Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000950170-24-065541

Options or other derivatives

  • Director acquired 11,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McGeorge Anne Director 2024-05-23 Grant or award · Stock Option (Right to Buy) +11,000 11,000 D
Loading xslF345X05/ownership.xml…